Navigation Links
Heygood, Orr & Pearson: Los Angeles Court Orders Watson Pharmaceuticals to Produce Documents, Provide Depositions in Fentanyl Patch Death Lawsuit
Date:3/21/2011

LOS ANGELES, March 21, 2011 /PRNewswire/ -- Attorneys from Dallas' Heygood, Orr & Pearson are announcing a Los Angeles Superior Court ruling that will require executives from Watson Pharmaceuticals Inc. (NYSE: WPI) and its subsidiary companies to testify under oath and produce key documents as part of a lawsuit over the death of a 37-year-old woman who died while using the company's fentanyl patch.

Attorney Michael Heygood represents the parents of Nicole Bristol, who died on Feb. 9, 2008, hours after applying a fentanyl patch manufactured by Corona, Calif.-based Watson. Fentanyl is a powerful narcotic painkiller that is often applied by a time-released adhesive patch. The drug is up to 100 times more powerful than morphine and often prescribed for chronic pain.

In the Los Angeles lawsuit, Monika Standing, et al. v. Watson Pharmaceuticals Inc., et al., No. BC-405990, Ms. Bristol's parents say their daughter suffered a lethal overdose as a result of a defective Watson fentanyl patch. Although the package insert in Ms. Bristol's prescription said she should have received 1.7 ng/ml of fentanyl, autopsy results showed that she died with 15ng/ml of fentanyl in her system. Fentanyl has been found to be lethal at a blood level of 3 ng/ml, with an average lethal concentration of 8 ng/ml.

The lawsuit says Watson officials used a faulty and unsafe "reservoir" design that is subject to manufacturing errors and can allow lethal amounts of the drug to leak onto a patient's skin. Although many competing companies utilize a "matrix" design that makes leaks impossible, Watson continues to use the "reservoir" design despite several recalls of Watson fentanyl patches and numerous lawsuits over related deaths around the country.

In the Bristol lawsuit, Watson has consistently objected to the family's requests for the company's executives, representatives and employees to testify under oath about its fentanyl products and to produce documents related to its manufacturing processes and related problems in the production of the Watson pain patch.

"With this court order, we will finally be able to see the key documents and get answers to important questions we've been waiting to ask for more than a year," says Mr. Heygood, lead counsel for the Bristol family. "This company should have to answer for making a product that we believe is the sole reason Ms. Bristol isn't here today."

The ruling signed March 11, 2011, by Judge Richard E. Rico orders Watson to produce company documents and emails requested by Mr. Heygood and other attorneys for the Bristol family by April 11, and for the company to make employees and corporate representatives available for depositions between April 11 and June 11.

"We are hopeful that this ruling finally convinces Watson Pharmaceuticals to take seriously the many deaths around the country related to their fentanyl patches, like the death of Nicole Bristol," says Mr. Heygood.

In 2007, Mr. Heygood and fellow firm attorney Jim Orr helped the family of a Florida man win a $5.5 million verdict in the nation's first federal trial over a defective fentanyl patch. The following year, the two attorneys won a $16.5 million verdict in Chicago, Illinois, for the family of a mother of three who died while using a fentanyl patch.

For more information, contact Bruce Vincent at 800-559-4534 or bruce@androvett.com.


'/>"/>
SOURCE Heygood, Orr & Pearson
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Midland Family Undergoes Bariatric Surgery at Hurley Medical Center--Loses 445 Pounds & Counting—Tells their Life-Saving Story to Media on March 18, 2011
2. Global Blood Pressure Monitoring & Measurement Instruments Industry
3. Global Respiratory Care Equipment & Supplies Industry
4. Ferring Pharmaceuticals, Inc. Congratulates R&B and Pop Icon Gloria Gaynor, Named Woman of the Year by Arthritis Foundation
5. Woman Files Suit in Beaumont, Texas Federal Court Against DePuy Orthopaedics and Johnson & Johnson Over Recalled Hip Device
6. Woman Files Suit in Federal Court Against DePuy Orthopaedics, Inc.,/Johnson & Johnson Over Recalled Hip Device
7. Cantel Medical Corp. to Present at The Sidoti & Company LLC Fifteenth Annual Emerging Growth Institutional Investor Forum
8. BioTox Sciences (BTS) Deploys eStudy™ Hosted Solution for Management of GLP & Non-GLP Preclinical Studies
9. Johnson & Johnson Acquires 98.89% of Issued Crucell Shares as of the End of the Subsequent Offering Period and Crucell Intends to Delist Crucell Ordinary Shares and ADSs
10. Adeona Receives Excellence in Science & Technology Award
11. Codexis Names Jacques Beaudry-Losique VP Corporate Development & Strategy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... , Dec. 2, 2016  PipelineRx, a leading medication ... be offering demonstrations of its SaaS-based telepharmacy platform, ... Health-System Pharmacists 2016 Midyear Clinical Meeting and Exhibition, ... . With nearly 300 hospital clients nationally, the ... technology designed to dramatically improve pharmacy operations, enhance ...
(Date:12/2/2016)... On Thursday, December 1st 2016, ... research, development and innovation in the biopharmaceutical industry at ... in the presence of Sergey Tsyb, Vice Minister of ... , Natalia Sanina, First Vice Chairman of the ... of Roszdravnadzor, National Service of Control in Healthcare, Sergey ...
(Date:12/2/2016)... , Dec. 2, 2016  Eli Lilly and ... financial guidance for 2017 and provide updated financial guidance ... also conduct a conference call on that day with ... company,s financial guidance. The conference call will ... general public can access a live webcast of the ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... ... build intelligent, connected applications, was named the best Sales Team of 2016 as ... announcement was made today by the Software & Information Industry Association (SIIA), the ...
(Date:11/30/2016)... ... November 30, 2016 , ... The Fertility ... designated as a Cigna Infertility Center of Excellence. The Cigna Center of Excellence ... “It’s an honor to be designated a Cigna Infertility Center of Excellence," said ...
(Date:11/30/2016)... ... 2016 , ... Standard Process, Inc. is proud to announce ... of the largest closely held companies headquartered in Wisconsin. This marks the company’s ... Process was awarded the Talent Award for providing outstanding employee benefits. , ...
(Date:11/30/2016)... ... November 30, 2016 , ... In ... been a focus of public policymakers and system stakeholders in many states. To ... its Medical Price Index for Workers’ Compensation, Eighth Edition (MPI-WC) . , ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... its orthopedic practice with the addition of new North Phoenix and Chandler locations. ... C. Lincoln North Mountain campus at 9327 North 3rd St, Suite 300 in ...
Breaking Medicine News(10 mins):